Abstract Details

Title Substitution of SCIg for IVIg in Immune-Mediated Neuropathy Patients Unable To Tolerate IVIg

Topic Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 132

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David S. Saperstein, MD (Center for Complex Neurology, EDS & POTS)	No disclosure on file
Todd D. Levine, MD (Honor Health)	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Rachel Couchenour, PharmD (Chelsea Therapueutics)	No disclosure on file

��ɫ����